Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 56; no. 3; pp. 779 - 781
Main Authors Quackenbush, Robert C., Horner, Thierry J., Williams, Vanessa C., Giampietro, Patricia, Lin, Thomas S.
Format Journal Article
LanguageEnglish
Published United States Informa Healthcare 01.03.2015
Taylor & Francis
Subjects
Adult
Aged
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Combined Modality Therapy
Female
Fever - etiology
Headache - etiology
Humans
Iodine Radioisotopes - adverse effects
Iodine Radioisotopes - therapeutic use
Kaplan-Meier Estimate
Lymphoma, Follicular - pathology
Lymphoma, Follicular - therapy
Male
Middle Aged
Nausea - etiology
Neoplasm Recurrence, Local
Radioimmunotherapy - methods
Rituximab - adverse effects
Rituximab - therapeutic use
Thrombocytopenia - etiology
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
ObjectType-Correspondence-1
ObjectType-Feature-3
content type line 66
ObjectType-News-4
ISSN:1042-8194
1029-2403
DOI:10.3109/10428194.2014.927461